Evaluation of AI for prostate cancer detection in biparametric-MRI screening population data - Takeaways - MDSpire

Evaluation of AI for prostate cancer detection in biparametric-MRI screening population data

  • By

  • Fredrik Langkilde

  • Magnus Gren

  • Jonas Wallström

  • Stefan Kuczera

  • Stephan E. Maier

  • December 8, 2025

  • 0 min

Share

  • 1

    MRI is recommended in Europe before biopsies for prostate cancer, reducing the number of biopsies and overdiagnosis.

  • 2

    AI-assisted workflows in MRI interpretation can potentially lower costs and improve efficiency in prostate cancer screening.

  • 3

    The study utilized data from the Göteborg Prostate Cancer Screening 2 Trial to train a neural network for prostate cancer detection.

  • 4

    A multiparametric MRI protocol was employed, with specific scan parameters for T2-weighted and diffusion-weighted imaging.

  • 5

    The reference standard for MRI examinations was determined by consensus readings from experienced radiologists using PI-RADS scoring.

Original Source(s)

Evaluation of AI for prostate cancer detection in biparametric-MRI screening population data

  • by Fredrik Langkilde, Magnus Gren, Jonas Wallström, Stefan Kuczera, Stephan E. Maier

  • December 8, 2025

Related Content

The effects of prostate volume and PI-RADS category on optimal PSA-density thresholds for biopsy decision-making

Suspended Lead Suits Linked to Lower Radiation in LAAO

Study shows suspended lead suits reduce head-level radiation exposure during left atrial appendage occlusion procedures

Evaluation of an artificial intelligence model based on multiparametric transrectal ultrasound for localizing clinically significant prostate cancer by simulation of targeted biopsies